Vol 74, Supp. III (2016)
Case studies
Published online: 2016-06-03
Non-vitamin K antagonist oral anticoagulant therapy in a patient with atrial fibrillation and concomitant prostate cancer
DOI: 10.5603/KP.2016.0082
Abstract
Oral anticoagulant therapy in patients with atrial fibrillation and concomitant malignancy is a serious clinical challenge. We present a case of a patient with prostate cancer treated with rivaroxaban due to a permanent atrial fibrillation. During a three-month follow-up period we did not observe any treatment-related adverse events.
Keywords: rivaroxabanatrial fibrillationmalignancy